Health and Wellbeing

Industry Capability Reports

  • digital_health_icr

    Intelligent Health Solutions
    Australian opportunities in digital health.

  • Why Australia for Clinical Trials 2021

    Why Australia for Clinical Trials 2021 (PDF, 3.33MB)
    Australia is a global destination for clinical trials due to its high quality and well-regulated health industry. The Australian ecosystem enables innovators to conduct clinical trials in an efficient and cost effective way under a streamlined approvals system and robust regulatory framework. Austrade developed a national slide deck ‘Why Australia for clinical trials’ that highlights Australia’s strength and capabilities for clinical trials.

  • Complementary medicine industry capability Report covre

    Complementary medicine (PDF, 911 KB)
    With a global reputation for quality and safety, backed by one of the strongest regulatory systems in the world, Australian complementary medicine products are a natural choice for consumers seeking to optimise their health.

  • Medical Devices Capability Report Cover

    Medical Devices and Diagnostics (PDF, 2MB)
    Australian medical technologies are making a global impact; solutions such as the cochlear implant (bionic ear) and continuous positive airway pressure (CPAP) devices for sleep apnoea are just two Australian inventions that have transformed the lives of people around the world.

  • Senior living health report cover

    Senior Living Health (PDF, 3.2MB)
    Australia offers world-class products, services and expertise to help other countries meet the challenges of an ageing population, and has many decades of experience in senior living and health care delivery.

Australian Seniors Health and Living Directory

Whether you are a vendor, purchaser or investor, the search features of the website will help you find the product, technology or service you are looking for.

Download the Australian Seniors Health and Living Directory

World-leading technology and innovation

Health and medical

Over the past decade, Australia’s health and medical industry has grown dramatically in size and reputation for its world leading technology, innovation, high professional skills, advanced research, development and robust health system.

It is characterised by a small number of global multinational companies (approximately 20 per cent of the industry) and a large number of small and medium-sized enterprises (80 per cent of the industry).

The health and medical industry is represented by manufacturers, specialised in niche applications in the fields of cardiovascular, diagnostic, hearing, orthopaedic, respiratory devices, as well as health IT, health infrastructure, services and clinical trials. The industry is also expected to advance rapidly into new fields of science, engineering, and nanotechnology to facilitate new innovations in the biomedical sphere and an increasing convergence of physical and biological technology platforms.

Australian innovation in this sector is showcased each year at key international events such as Medica Germany, Arab Health, HOSPIMedica Asia, Bio USA, HIMSS USA and HIMSS Asia-Pacific.

The key growth areas are:

  • Medical and surgical equipment and devices
  • Health IT
  • Health infrastructure and services
  • Clinical trials

Medical and surgical equipment and devices

  • Imaging/monitoring equipment
  • Biomedical devices and implants
  • Surgical equipment, general hospital supplies
  • Diagnostic devices
  • Laboratory equipment
  • Dental equipment
  • Health-related software
  • Drug delivery

Medical devices in Australia are regulated by the Therapeutic Goods Administration (TGA). The TGA uses a risk-based approach to assess devices before they are entered onto the Australian Register of Therapeutic Goods.

Australia’s medical device industry can list among its distinct competitive advantages its reduced time to market compared with drug discovery, its comparatively highly skilled workforce and its geographic position within the Asia Pacific region.

The medical device industry is supported by Australia's entrepreneurial and globally competitive Precision Engineering Industry (PEI) which has critical links to Australia's automotive industry. The PEI researches, designs, develops, manufactures and verifies high-accuracy components, high-precision machines and systems. PEI enterprise is practised in a variety of technical areas, from engineering – mechanical, electrical, optical, and industrial - to medical devices, ergonomics, human support technology, materials science, physics, chemistry, mathematics, and computer science.

Health IT

  • Health messaging
  • Electronic health record
  • Hospital management and patient administration systems
  • Tele-health
  • Clinical information systems, eg. pharmacy, pathology
  • Asset management and supply chain management
  • Health payment solutions

The health information technology and informatics field is a rapidly expanding sector both in Australia and internationally. Australia’s large geographic size has driven advancement in technology for delivering health services across diverse areas making Australia a global leader in areas such as health messaging and electronic health record architecture.

Hospital spending on health IT initiatives also drives the industry and innovative technologies have emerged in electronic information sharing with general practice and specialised physicians, community, mental health and aged care providers.

Australian healthcare agencies have provided their support behind a global push to unite the medical software industry though a deal linking similar government e-health development efforts in the UK, Canada and the US. The Open Health Tools consortium, which has already secured the backing of IBM and Oracle in addition to a raft of smaller operators, said Australia would be represented by the National e-Health Transition Authority, along with the US Veterans Health Administration and the National Health Service in the UK.

Health infrastructure and services

  • Specialist and alternative health services such as acupuncture, homoeopathy and naturopathy
  • Hospital and health facilities design, architecture and interiors
  • Hospital management
  • Delivery of turnkey hospital solutions via a HealthTeam Australia consortium
  • Health consultancies (including hospital accreditation), particularly in developing economies
  • Tele-health services such as tele-radiology or outsourced back office support
  • Medical staff recruitment services
  • Healthcare professional training and education
  • Aged care services
  • Pathology/diagnostic services/DNA testing
  • Medical tourism

Clinical trials

Clinical trials for multinational drug companies on the multi-million dollar scale are now managed by specialised outsourcers – known as contract research organisations (CROs) – with Australian firms in this sector winning a bigger proportion of these projects because of greater efficiency, speed and open regulatory (Clinical Trial Notification/Exemption) system.

Australia is internationally recognised for its work in niche areas of the pre-clinical phase, such as ICN Firefly, and emerging strengths in biomedicine clinical trials. Early innovative drug trials are also becoming a sizeable niche.

Natural healthcare and wellbeing

The domestic Australian natural (complementary) healthcare industry is robust and significant . Market research shows that the popularity of natural healthcare products is increasing with a growth rate of seven per cent year on year. Three-quarters of Australians, including 92 per cent of women aged 20-24; take at least one dietary supplement and a quarter of the population visit complementary healthcare practitioners each year.

The Australian industry continues to grow to meet these requirements. Already attuned to alternative approaches to health, discerning baby boomers (Australia’s largest population group) increasingly demand greater choice and adopt a preventative healthcare approach to maintaining healthier lives. In Australia, the fastest growth areas are nutritional oils, men’s health and eye health.

The local natural healthcare industry benefits from Australia’s unrivalled biodiversity. Whilst still being an advanced industrialised economy, Australia is home to nearly 10 per cent of the earth’s plant and animal life. Many of these species unique to Australia underpin a wide variety of highly distinctive natural healthcare products. The Australian industry is also enriched through the influences of local indigenous culture and generations of migrants from all over the world.

Products are manufactured to some of the highest standards in the world based on GMP validation and stringent therapeutic regulations. These standards are maintained by the Therapeutic Goods Administration (TGA) through a transparent approval process, strict manufacturing compliance guidelines and effective post-market monitoring. The TGA register also supports the natural healthcare products industry with evidence-based research, monitoring and safety data. These elements combine to allow Australian manufacturers to supply world-class products at globally competitive prices.

The Australian natural healthcare industry (which is fully integrated into our national health system), presents a wealth of business opportunities at every level – from suppliers of raw materials and ingredients through to manufacturers, distributors, wholesalers, sponsors, consultants and retailers.

Useful links